michigan semaglutide side effect legal team The FDA sent a warning letter to the maker of Ozempic and Wegovy over unreported potential GLP-1 effects. Here's what to know Semaglutide vs Tirzepatide: Effectiveness, Side

Clinical overview of hepatitis B

(, , ) 30-40

While patients should generally not discontinue tirzepatide without medical guidance due to potential glycemic deterioration, they should immediately stop the medication and seek urgent medical care if they develop symptoms of pancreatitis (severe, persistent abdominal pain, sometimes radiating to the back) or serious allergic reactions

GLP-1 receptor agonist medications (including semaglutide, dulaglutide, liraglutide, exenatide, and lixisenatide) are typically considered for type 2 diabetes when: Triple therapy with other diabetes medications is not effective, not tolerated, or contraindicated The person has a BMI 35 kg/m (adjusted by 2.5 kg/m for people from South Asian, Chinese, other Asian, Black African, or African-Caribbean backgrounds) and specific weight-related psychological or medical problems A lower BMI threshold may be appropriate if weight loss would benefit other obesity-related comorbidities Insulin would not be appropriate or acceptable to the person Treatment is usually continued only if there is a beneficial metabolic response (reduction in HbA1c and weight) after 6 months